NR3C1 and breast cancer: Based on the finding that GR signalling did not depend on the presence of the ligand, we screened genes that exhibited a significant positive and negative correlation with NR3C1 in breast cancer tissue samples (10,455 samples analyzed by 57 microarray studies and 4421 samples analyzed by three RNAseq studies).